William Resides
Directeur Général chez FINDIT
Profil
William Resides is the founder of NuLife Sciences, Inc. (founded in 2019) and the current Director, Chief Executive & Financial Officer at Findit, Inc. Mr. Resides is also the founder of BioRegenx, Inc.
Postes actifs de William Resides
| Sociétés | Poste | Début |
|---|---|---|
| FINDIT | Directeur Général | 08/03/2024 |
Anciens postes connus de William Resides
| Sociétés | Poste | Fin |
|---|---|---|
NuLife Sciences, Inc.
 NuLife Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services NuLife Sciences, Inc. a biomedical company, which engages in advancing human organ transplant and tissue repair technology, and medical research. The company was founded by Derek Cahill on October 15, 2013 and is headquartered in Newport Beach, CA. | Directeur Général | - |
BioRegenx, Inc.
 BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding private company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FINDIT | Technology Services |
| Entreprise privées | 2 |
|---|---|
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding private company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Health Technology |
NuLife Sciences, Inc.
NuLife Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services NuLife Sciences, Inc. a biomedical company, which engages in advancing human organ transplant and tissue repair technology, and medical research. The company was founded by Derek Cahill on October 15, 2013 and is headquartered in Newport Beach, CA. | Commercial Services |
